Download PDF

Dr Michael Fuchsjäger, Chairman of the ESR Board of Directors (Graz, Austria) and Iva Biondić Špoljar of University Hospital Dubrava (Zagreb, Croatia) co-moderated a session on predictive and prognostic models in breast imaging. In this session, three experts presented on the use of Magnetic Resonance Imaging (MRI) markers in neoadjuvant chemotherapy for breast cancer.

 

Dr Fioana Gilbert (University of Cambridge) discussed recent research study involving 82 breast cancer patients that evaluated Dynamic Contrast-Enhanced MRI (DCE-MRI) use for neoadjuvant breast cancer chemotherapy. Standard prognostic factors were better predictors of tumour cell reduction to chemotherapy (pCR, pathological complete response) than DCE-MRI vascular kinetics at early timepoints. However, combining standard prognostic factors with DCE-MRI did improve prediction of pCR for hormone receptor positive (HR+) and triple negative (TN) breast cancers.

  


Dr Anna van der Voort (Netherlands Cancer Institute) presented results that diffusion-weighted imaging MRI (DWI-MRI) did not clinically increase the performance of DCE-MRI for identifying a pCR in HR+ breast cancer after neoadjuvant chemotherapy.

 

Dr Maria Clotitlde Sciandrello (University of Turin) presented research in 164 patients describing MRI morphological criteria that can predict axillary lymph node (ALN) response after neoadjuvant chemotherapy. Irregular margins and the absence of a fatty hilum reliably predicted pre-therapy disease and poor pCR.

 

For more Women's Health news Click Here


Source: ECR 2022 Overture  

«« HIMSS 2022 is 14-18 March!


Using Social Media to Engage Hospital Consumers »»


breast imaging, breast cancer, Women's Health, ECR 2022

Latest Articles

  • Pharmacist in the ICU

    Pharmacists play a crucial role in the ICU, where patients often require complex medication regimens, including multiple medications and intravenous therapies. The role of a critical care pharmacist is multifaceted and vital to ensuring optimal patient care in the critical care setting.   Cr

    READ MORE
  • Defining Medicines Optimisation in the Intensive Care Unit

      Complex polypharmacy and pathophysiology are common in the intensive care unit (ICU). Medicines optimisation is essential to deliver safe, effective, and individualised pharmacotherapy. This is ideally performed by a specialised ICU pharmacist.   Introduction Medicines ar

    READ MORE
  • Critical Care Pharmacists Save Lives

      The purpose of this review is to discuss the role of critical care pharmacists on the interprofessional healthcare team in the care of critically ill patients and explore current gaps in the provision of comprehensive medication management.   Introduction   “The patient’s

    READ MORE
Breast Imaging, Women's Health , ECR 2022, Breast Cancer Breast Imaging: Predictive and Prognostic Models [ECR 2022]